The LimePay financial metrics don't say a word on the associated costs. It's unlikely to be positive... and restructuring the teams would be costly.
The runway calculation does not include items moved to IP which are operational costs related to R&D. So in truth the quarterly run rate is a loss of about $2mio. Less than a year to go when you include the R&D rebate. With LimePay, that will be less.
There is some revenues that have been precisely described in a public announcement, that are "promising". But it seems clear that they must come in soon, as otherwise another CR is on the card.
The August 25 options look toast. Hopefully the CFO does not rely on that cash...
SPX Price at posting:
1.1¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)